Contract Pharmacal Executive and Leadership Team

Eric Antman, the Chief Financial Officer at Contract Pharmacal, directs all financial strategy and fiscal operations. Overseeing budgeting, forecasting, and financial reporting, Antman ensures robust financial health and compliance across the organization. This leadership role involves managing capital allocation, optimizing investment strategies, and securing funding to support Contract Pharmacal's manufacturing and packaging initiatives for pharmaceuticals, over-the-counter drugs, and dietary supplements. By analyzing market trends and economic conditions, Eric Antman drives financial planning to support global distribution and operational scaling. His expertise is critical in maintaining profitability and enabling strategic growth for the company's diverse product lines, ensuring sustained financial stability and shareholder value.

Jeffrey Reingold, the Chief Operating Officer at Contract Pharmacal, orchestrates all manufacturing and operational processes. Reingold oversees the end-to-end production lifecycle, from raw material sourcing to final product packaging, ensuring adherence to stringent quality standards for pharmaceuticals, over-the-counter drugs, and dietary supplements. This executive position involves optimizing supply chain logistics, enhancing production efficiency, and implementing advanced manufacturing technologies to meet global demand. By driving operational excellence, Jeffrey Reingold ensures seamless execution of contracts with pharmaceutical companies, retailers, and wholesalers worldwide. His focus on operational integrity directly supports Contract Pharmacal's mission to deliver high-quality products consistently and reliably, underpinning the company's reputation for dependable manufacturing.

Mark Wolf, the President at Contract Pharmacal, provides overarching executive direction and strategic vision for the company. Wolf guides the organization's growth initiatives, market positioning, and long-term objectives, ensuring alignment across all functional areas. This leadership role involves fostering key relationships with clients, partners, and stakeholders, driving business development and expanding Contract Pharmacal's global footprint in pharmaceutical, over-the-counter drug, and dietary supplement manufacturing and packaging. By championing innovation and operational excellence, Mark Wolf steers the company towards sustained success and market leadership. His comprehensive oversight ensures the continued delivery of high-quality products and services to a worldwide customer base.

Robyn Wolf-Eagle, the Chief Human Resources Officer at Contract Pharmacal, leads all human capital strategies and organizational development. Wolf-Eagle oversees talent acquisition, employee relations, compensation, and benefits programs, fostering a productive and compliant work environment. This critical role involves developing and implementing HR policies that support the company's manufacturing and packaging operations for pharmaceuticals, over-the-counter drugs, and dietary supplements. By cultivating a strong organizational culture and ensuring employee engagement, Robyn Wolf-Eagle drives workforce performance and retention. Her strategic direction is essential for aligning human resources with Contract Pharmacal's business objectives, supporting its global reach and commitment to quality manufacturing.